Literature DB >> 3101813

Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies.

R Shinebaum, C C Blackwell, P J Forster, N P Hurst, D M Weir, G Nuki.   

Abstract

Gram negative bacteria precipitate reactive arthritis and may be concerned in the pathogenesis of ankylosing spondylitis and other spondyloarthropathies. Susceptibility to many infectious agents is associated with ABO blood group or secretor state, or both. The distribution of the ABO blood group or secretor state, or both, was therefore determined in 87 patients with ankylosing spondylitis and 32 with other forms of spondyloarthropathy. The prevalence of non-secretors was significantly increased in the total patient group (54/114; 47%) and in the subgroup with ankylosing spondylitis (41/84; 49%) compared with local controls (89/334; 27%) (p less than 0.001). Other subgroups of patients showed a similarly increased prevalence of non-secretion (33-47%). The distribution of ABO blood groups did not differ between patients and controls. The association between non-secretor state and ankylosing spondylitis strengthens the hypothesis that ankylosing spondylitis is a form of reactive arthritis. It also suggests several pathogenic mechanisms which may be relevant to the initial hostparasite interaction in ankylosing spondylitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3101813      PMCID: PMC1245226          DOI: 10.1136/bmj.294.6566.208

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  22 in total

1.  Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants.

Authors:  L H Miller; S J Mason; J A Dvorak; M H McGinniss; I K Rothman
Journal:  Science       Date:  1975-08-15       Impact factor: 47.728

2.  Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae.

Authors:  C C Blackwell; K Jónsdóttir; M Hanson; W T Todd; A K Chaudhuri; B Mathew; R P Brettle; D M Weir
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

3.  Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli.

Authors:  H Lomberg; B Cedergren; H Leffler; B Nilsson; A S Carlström; C Svanborg-Edén
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

Review 4.  Joseph J. Bunim Memorial Lecture. HLA-B27 and the inheritance of susceptibility to rheumatic disease.

Authors:  D A Brewerton
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

5.  Reactive arthritis.

Authors:  C R Hind
Journal:  Postgrad Med J       Date:  1982-03       Impact factor: 2.401

6.  Serum IgG, IgM, and IgA levels in ankylosing spondylitis.

Authors:  E M Veys; M van Leare
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

7.  Reiter's syndrome. Evaluation of preliminary criteria for definite disease.

Authors:  R F Willkens; F C Arnett; T Bitter; A Calin; L Fisher; D K Ford; A E Good; A T Masi
Journal:  Arthritis Rheum       Date:  1981-06

8.  Ankylosing spondylitis: klebsiella and HL-A B27.

Authors:  R Ebringer; D Cooke; D R Cawdell; P Cowling; A Ebringer
Journal:  Rheumatol Rehabil       Date:  1977-08

9.  Faecal carriage of klebsiella by patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  R E Warren; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

10.  Frequency of faecal Klebsiella aerogenes in patients with ankylosing spondylitis and controls with respect to individual features of the disease.

Authors:  C J Eastmond; H E Willshaw; S E Burgess; R Shinebaum; E M Cooke; V Wright
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

View more
  10 in total

1.  AB0 and Lewis blood groups in reactive arthritis.

Authors:  R Tertti; H Järvinen; R Lahesmaa; U Yli-Kerttula; A Toivanen
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

2.  Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates.

Authors:  J A Morris; M J Gardner
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

3.  Increased prevalence of non-secretors in patients with Graves' disease: evidence for an infective aetiology?

Authors:  A Collier; A W Patrick; A D Toft; C C Blackwell; V James; D M Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-23

4.  Secretor state of patients with insulin dependent or non-insulin-dependent diabetes mellitus.

Authors:  C C Blackwell; V S James; D M Weir; J D Gemmill; A W Patrick; A Collier; B F Clarke
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-24

5.  ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers.

Authors:  A Mentis; C C Blackwell; D M Weir; C Spiliadis; A Dailianas; N Skandalis
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

6.  Pseudomonas colonization in cystic fibrosis: lack of correlation with secretion of ABO blood group antigens.

Authors:  D Mulherin; M J Coffey; M J Keogan; P O'Brien; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1990-07       Impact factor: 1.568

Review 7.  Probing for genes in seronegative spondyloarthropathy.

Authors:  M Stone; M M Khraishi; P Rahman
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

8.  Immunoglobulin allotype Gm(1,2;21) in ankylosing spondylitis with peripheral arthritis.

Authors:  R Mierau; C A von Mühlen; H Zarnowski; E Genth; P W Hartl
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

9.  Association between secretor status and respiratory viral illness.

Authors:  M W Raza; C C Blackwell; P Molyneaux; V S James; M M Ogilvie; J M Inglis; D M Weir
Journal:  BMJ       Date:  1991-10-05

10.  Lewis phenotype, secretor status, and coeliac disease.

Authors:  W Dickey; J D Wylie; J S Collins; K G Porter; R G Watson; J C McLoughlin
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.